Nestor, Sean M.
Mir-Moghtadaei, Arsalan http://orcid.org/0000-0001-9337-7840
Vila-Rodriguez, Fidel http://orcid.org/0000-0002-8273-8820
Giacobbe, Peter
Daskalakis, Zafiris J.
Blumberger, Daniel M.
Downar, Jonathan http://orcid.org/0000-0002-5140-174X
Funding for this research was provided by:
the Norris Scholar Award and the Labatt Family Network for Research in Depression, Department of Psychiatry, University of Toronto
Gouvernement du Canada | Canadian Institutes of Health Research (MOP-136801, MOP-136801, MOP-136801, MOP-136801, MOP-136801)
Article History
Received: 7 July 2021
Revised: 6 November 2021
Accepted: 13 December 2021
First Online: 2 February 2022
Competing interests
: The funder of the study (Canadian Institutes of Health Research) and the device manufacturer (MagVenture) that provided equipment had no role in study design, data collection, data analysis, data interpretation, or writing of the report. SMN received research financial support from the Norris Scholar Award and the Labatt Family Network for Research in Depression, Department of Psychiatry, University of Toronto, and the Sunnybrook Foundation. SMN reports no conflicts of interest. AM-M reports no conflicts of interest. DMB has received research support from Brain Canada, CIHR, NIH, the Weston Brain Institute, and the Temerty Family through the CAMH Foundation and the Campbell Research Institute; he has received in-kind equipment support for investigator-initiated studies from Magventure, he has received research support and in-kind equipment support for an investigator-initiated study from Brainsway and is the site principal investigator for three sponsor-initiated studies for Brainsway; he has received medication supplies for an investigator-initiated trial from Indivior; and he has participated on an advisory board for Janssen. JD has received research support from the Arrell Family Foundation, the Buchan Family Foundation, Brain Canada, the Canadian Biomarker Integration Network in Depression, the Canadian Institutes of Health Research (CIHR), the Klarman Family Foundation, NIH, the Ontario Brain Institute, the Toronto General and Western Hospital Foundation, and the Weston Family Foundation; he has received travel stipends from Lundbeck and ANT Neuro; he has served as an advisor for BrainCheck, Neurostim TMS Centers, Restorative Brain Clinics, and TMS Neuro Solutions. FV-R has received research support from Brain Canada, CIHR, the Michael Smith Foundation for Health Research, and the Vancouver Coastal Health Research Institute, and he has participated on an advisory board for Janssen. PG has received research support from the CIHR, NIH, and Veteran’s Affairs Canada and has been an unpaid consultant for St. Jude Medical. He has served on an advisory board for Janssen and Bristol Myers Squibb. ZJD has received research and equipment in-kind support for an investigator-initiated study through Brainsway Inc. and Magventure Inc. His work was supported by the Ontario Mental Health Foundation (OMHF), the Canadian Institutes of Health Research (CIHR), the National Institutes of Mental Health (NIMH), and the Temerty Family and Grant Family and through the Centre for Addiction and Mental Health (CAMH) Foundation and the Campbell Institute.